These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 32725719)

  • 1. Secukinumab monotherapy successfully treated severe refractory type V (atypical juvenile) pityriasis rubra pilaris: A case report and literature review.
    Liang JY; Ye RX; Tian X; Zhang SQ; Zhang XB
    Dermatol Ther; 2020 Nov; 33(6):e14097. PubMed ID: 32725719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of severe pityriasis rubra pilaris with secukinumab in a 3-year-old boy.
    Xu YH; Dong DD; Lin YF; Wang Q; Huang LM; Shi JQ
    Clin Exp Dermatol; 2022 Nov; 47(11):2043-2045. PubMed ID: 35906074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secukinumab for the treatment of adult-onset pityriasis rubra pilaris: a single-arm clinical trial with transcriptomic analysis.
    Boudreaux BW; Pincelli TP; Bhullar PK; Patel MH; Brumfiel CM; Li X; Heckman MG; Pittelkow MR; Mangold AR; Sluzevich JC
    Br J Dermatol; 2022 Nov; 187(5):650-658. PubMed ID: 35701384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate treatment in a case of juvenile pityriasis rubra pilaris.
    Boyd AH; Polcari IC
    Pediatr Dermatol; 2018 Jan; 35(1):e62-e63. PubMed ID: 29044698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab monotherapy as first-line treatment for adult-onset pityriasis rubra pilaris: case report and review of the literature on biologic therapy.
    Müller H; Gattringer C; Zelger B; Höpfl R; Eisendle K
    J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S65-70. PubMed ID: 19119128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secukinumab emerges as a rapidly effective therapy for pityriasis rubra pilaris.
    Bonomo L; Levitt JO
    Cutis; 2018 May; 101(5):367-369. PubMed ID: 29894526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of a child's pityriasis rubra pilaris (PRP) with ustekinumab and acitretin.
    Katharina M; Sylvia S; Matthias B; Ulrich M; Martin L
    Pediatr Dermatol; 2022 Jul; 39(4):659-661. PubMed ID: 35859269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory pityriasis rubra pilaris treated with etanercept, adalimumab, or ustekinumab: A retrospective investigation.
    Maloney NJ; Hisaw LD; Worswick S
    Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 29034547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologics for Treatment of Pityriasis Rubra Pilaris: A Literature Review.
    Chandy RJ; Chokshi A; Tan I; Feldman SR
    J Cutan Med Surg; 2024; 28(3):269-275. PubMed ID: 38549359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ustekinumab treatment of pityriasis rubra pilaris: A report of five cases.
    Napolitano M; Lembo L; Fania L; Abeni D; Didona D; Didona B
    J Dermatol; 2018 Feb; 45(2):202-206. PubMed ID: 29080273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adalimumab for the treatment of pityriasis rubra pilaris: a case report.
    Wassef C; Lombardi A; Rao BK
    Cutis; 2012 Nov; 90(5):244-7. PubMed ID: 23270195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic sclerosis in a patient with pityriasis rubra pilaris.
    Frikha F; Frigui M; Masmoudi H; Turki H; Bahloul Z
    Pan Afr Med J; 2010 Aug; 6():6. PubMed ID: 21436949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pityriasis rubra pilaris: treatment with biologics - a new promising therapy?
    Ivanova K; Itin P; Haeusermann P
    Dermatology; 2012; 224(2):120-5. PubMed ID: 22508269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of IL-23 inhibitors including risankizumab and guselkumab in the treatment of pityriasis rubra pilaris.
    Rahman SM; Ahmed F; Haque A
    Arch Dermatol Res; 2024 Jun; 316(6):334. PubMed ID: 38844710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult onset pityriasis rubra pilaris.
    Sehgal VN; Srivastava G; Dogra S
    Indian J Dermatol Venereol Leprol; 2008; 74(4):311-21. PubMed ID: 18797049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circumscribed Juvenile Pityriasis Rubra Pilaris (Type 4) Koebnerising after a Hot Water Burn: Mild Disease with Maximum Koebner Response.
    Acar EM; Has S; Kilitci A; Kemeriz F
    Acta Dermatovenerol Croat; 2019 Mar; 27(1):47-49. PubMed ID: 31032794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Presentation of Pityriasis Rubra Pilaris Mimicking Tinea Corporis: Diagnostic Challenges of a Rare Skin Condition.
    Abang Hashim DH; Ismail IA; Tawil Z; Abd Halim H
    Am J Case Rep; 2022 Aug; 23():e936906. PubMed ID: 35988013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of pityriasis rubra pilaris with adalimumab - case report.
    Bravo EA; Carrion L; Paucar SM; Mendoza R; Rivera C
    Dermatol Online J; 2014 Apr; 20(4):22374. PubMed ID: 24746310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Juvenile pityriasis rubra pilaris: report of 28 cases in Taiwan.
    Yang CC; Shih IH; Lin WL; Yu YS; Chiu HC; Huang PH; Cheng YW; Lee JY; Chen W
    J Am Acad Dermatol; 2008 Dec; 59(6):943-8. PubMed ID: 18819727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Biologics in Pityriasis Rubra Pilaris Refractory to First-Line Systemic Therapy: A Systematic Review [Formula: see text].
    Naidoo A; Sibbald C; Fleming PJ; Piguet V
    J Cutan Med Surg; 2020; 24(1):73-78. PubMed ID: 31691587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.